Gail Schwartz is an Ophthalmology physician. OpenAlex indexes 60 publications with 1,366 citations (h-index 18).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
6565 N Charles St
Suite 302
Baltimore, MD 212046800
Telephone
410-825-9225Registry record last updated 17 Nov 2009.
Industry payments
15 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ABBVIE INC.Program year202514 payments
- Harrow Eye, LLCProgram year20252 payments
- Glaukos CorporationProgram year20252 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
79.5%Prostaglandin Analog39.5%Latanoprost66%Lumigan27%Travoprost6%Bimatoprost2%Part D≥397 patientsCarbonic Anhydrase Inhibitor23.3%Dorzolamide-Timolol74%Dorzolamide Hcl9%Simbrinza9%Brinzolamide5%Azopt1%Acetazolamide1%Part D<11 patients+ 6 more classes in this area
Cardiovascular
15.7%Beta blocker15.7%Timolol Maleate92%Betaxolol Hcl9%Part D<11 patientsMusculoskeletal
3.4%Cyclooxygenase Inhibitor3.4%Ketorolac Tromethamine100%Part D≥139 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Patient Journey After Intensification of Topical Glaucoma Therapy - a US Claims-Based Analysis2019
Similar KOLs
Other experts from the same institution or the same specialty.
Ali Bijani
Babol University of Medical Sciences
Hamid Asayesh
Ayatollah Boroujerdi University
John J. Huang
Isfahan University of Medical Sciences
Fotis Topouzis
National University of Singapore
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”